Sana to open new CGT manufacturing facility

By The Science Advisory Board staff writers

July 15, 2021 -- Sana Biotechnology has signed a lease to develop a 163,000-sq-ft manufacturing facility in Fremont, CA, to support the manufacture of its late-stage clinical development and early commercial cell and gene therapy (CGT) candidates.

The facility will be designed to provide manufacturing capabilities across the company's portfolio, including allogeneic T cell, viral vector, and pluripotent stem cell production.

The facility's location is in close proximity to Sana's existing technical and scientific capabilities, the firm said. Sana also intends to work with contract manufacturing partners to advance its candidates to the clinic as early as next year.

PerkinElmer to acquire Horizon Discovery for $383M
PerkinElmer has reached an agreement to acquire Horizon Discovery Group with an all-cash offer of approximately $383 million. The transaction is...

Copyright © 2021 scienceboard.net


Conferences
Cell & Gene Meeting on the Mesa
October 11-13
Carlsbad, California United States
IDWeek 2022
October 19-23
District of Columbia United States
American Society of Human Genetics Annual Meeting
October 25-29
Los Angeles, California United States
International Society for Pharmaceutical Engineering Annual Meeting
October 30 - November 2
Orlando, Florida United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter